The activation of FXR in the gut, however, was beneficial for lipid metabolism as it could inhibit lipid uptake and ameliorate NAFLD (FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption). This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatotic liver disease.